DocGo Inc. (DCGO) Q3 2025 10-Q Quarterly Report
DocGo Inc. (DCGO) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 10, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
DocGo Inc. Q3 2025 10-Q Analysis
Risk Factors
- • New goodwill impairment risk triggered by sustained revenue decline in Mobile Health Services segment Q3 2025
- • Material goodwill impairment charge of $8.7M and intangible asset charge of $8.0M recorded in Q3 2025
- • Regulatory risk unchanged; no new compliance or legal issues disclosed beyond 2024 10-K
- • Operational risk from deteriorating performance and forecasts in Mobile Health Services impacting near-term results
- • Financial risk from asset impairments may affect liquidity and financial condition due to significant charges against goodwill and intangible assets
DocGo Inc. Q3 2025 Quarterly FinancialsXBRL
Revenue
$71M
▼ -48.9% YoY▼ -11.9% QoQ
Net Income
-$28M
▼ -605.1% YoY▼ -35.1% QoQ
Operating Margin
-59.3%
▼ -6659bp YoY▼ -3754bp QoQ
Net Margin
-39.2%
▼ -4318bp YoY▼ -1365bp QoQ
ROE
-10.3%
Total Assets
$354M
EPS (Diluted)
$-0.28
▼ -660.0% YoY▼ -133.3% QoQ
Operating Cash Flow
$2M
▼ -94.7% YoY▼ -95.1% QoQ
Source: XBRL data from DocGo Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on DocGo Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.